COVID-19: Vaccines – what are they and how do they work (current and trials)

R. Boyton (London, United Kingdom)

Source: ERS Course 2021 - COVID-19: State of the art
Number: 5

Webcast

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Boyton (London, United Kingdom). COVID-19: Vaccines – what are they and how do they work (current and trials). ERS Course 2021 - COVID-19: State of the art

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Maria Nerea Zabala Urionaguena - 18.06.2021 08:47
There is still a great lack of coordination between speed in manufacturing and shipping to countries, especially those with less development.
You must Login to comment this presentation.


Related content which might interest you:
Vaccines - early clinical trials
Source: Virtual Congress 2020 – Management prevention
Year: 2020

Clinical trials during the COVID-19 pandemic: research design and lessons
Source: Eur Respir Monogr 2021; 94: 214-231
Year: 2021


Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial
Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment
Year: 2021



Delivery room management: current evidence from multi-centre trials: Support trial
Source: Research Seminar 2010 - Managing the lung of the extremely low gestational age neonate (ELGAN) in the delivery room
Year: 2010

Impact of single-limb (SL) versus two-limb (TL) low load/high-repetition resistance training (LLHR-RT) on clinical outcomes in people with COPD – a randomized controlled trial.
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018



Noninvasive strategies in COVID-19: epistemology, randomised trials, guidelines, physiology
Source: Eur Respir J, 57 (2) 2004247; 10.1183/13993003.04247-2020
Year: 2021



Bronchodilator response and airway cytology as parameters for asthma control: A randomized clinical trial Protocol ID: APITA, NCT00597064, on August 1st, 2008
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Critical review of the current management of pleural infection in a UK district general hospital. Applying the MIST II (multicentre intrapleural sepsis trial) evidence to our current practice
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


The Northjutland COPD prevention study (NCPS)
Source: Eur Respir J 2006; 28: Suppl. 50, 447s
Year: 2006

Delivery room management: current evidence from multi-centre trials: COIN Trial
Source: Research Seminar 2010 - Managing the lung of the extremely low gestational age neonate (ELGAN) in the delivery room
Year: 2010


Pooled analyses of five phase 2b studies support dose selection of glycopyrrolate-formoterol (GFF) MDI (PT003) 18/9.6 μg for phase III development
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


Applying telemonitoring (TMon) post-admission for COPD, at scale: Preliminary findings from a large European trial
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016


Late Breaking Abstract: The ERS recommendations on smoking cessation: Can they be used in clinical practice? The ICEBERG project (Implementation of smoking CEssation in respiratory Patients according to the ERS Guidelines)
Source: Annual Congress 2010 - Education for smoking control
Year: 2010

The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008


A self-management programme of activity coping and education (SPACE) for COPD: 6 week results from a randomised controlled trial
Source: Annual Congress 2012 - The best abstracts in chronic care
Year: 2012

Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?
Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018
Year: 2018



Safety, pharmacodynamics (PD) and pharmacokinetics (PK) of darotropium (DARO) and vilanterol (VI) in healthy subjects: Two phase 1 studies
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013